Life Science Company News

Reset
Results 101 - 120 out of 500 displayed.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Daré Bioscience Announces Positive Topline Data from the Exploratory Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal Disorder

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Daré Bioscience, Inc.

Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Rani Therapeutics, LLC

Portage Biotech Reports Updated Interim Data for Lead iNKT Engager, PORT-2, in a Phase 1/2 Trial for the Treatment of Advanced Melanoma and Metastatic Non-Small Cell Lung Cancer at the 2023 American Society for Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Portage Biotech, Inc.

Immutep Reports Final Positive Data in 2nd Line Head and Neck Squamous Cell Carcinoma at ASCO 2023 Annual Meeting

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Immutep Limited

Intra-Cellular Therapies to Present at the Goldman Sachs 44th Annual Global Healthcare Conference

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Intra-Cellular Therapies, Inc.

Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Atreca, Inc.

Onconova Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Annual Meeting

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Onconova Therapeutics, Inc.

NexImmune Presents Initial Positive Data from the NEXI-001 Phase 1 Trial for Relapsed/Refractory Post Allo-HSCT AML at the American Society of Clinical Oncology 2023 Annual Meeting

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  NexImmune, Inc.

Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  CohBar, Inc.

Amedisys Announces Receipt of Unsolicited Proposal From Optum

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Amedisys

Poster Highlighting Qualigen Therapeutics’ Pan-RAS Inhibitor Platform Presented at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Qualigen Therapeutics, Inc.

Ambrx Appoints Jared Kelly as General Counsel

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Ambrx, Inc.

Tarsus to Present at the Jefferies Global Healthcare Conference

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Tarsus Pharmaceuticals, Inc.

Surrozen Publishes Study in Nature Communications Demonstrating the Promise of a Fzd4 Wnt Antibody in Treating Ischemic Stroke

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Surrozen, Inc.

T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for Candida Auris Diagnostic Test

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  T2 Biosystems, Inc.

Lucy Scientific Discovery Announces Proposal to Acquire Pasithea Therapeutics Corp.

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Lucy Scientific Discovery Inc.

Shanghai Escugen Biotechnology Co., Ltd., a partner of Levena Biopharma, a Sorrento Company, releases positive results from a first-in-human study of ESG401, a TROP2 Antibody Drug Conjugate in patients with locally advanced/metastatic solid tumors at

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Sorrento Therapeutics, Inc.

Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Novartis AG | Novan, Inc.

Janssen Announces Erdafitinib Improved Overall Survival Versus Chemotherapy in Patients with Metastatic or Unresectable Urothelial Carcinoma and Selected Fibroblast Growth Factor Receptor Gene Alterations After Prior Anti-PD-(L)1 Treatment

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Janssen Pharmaceutica NV

Defender Pharmaceuticals Reports Positive Results from Pivotal Phase III Clinical Trial of Intranasal Scopolamine for the Prevention of Nausea and Vomiting Induced by Motion

Read more ››
By: GlobeNewswire - 05 Jun 2023
Related companies:  Defender Pharmaceuticals, Inc.
Results 101 - 120 out of 500 displayed.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »